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Abstract
PDZ domains recognise short sequence motifs at the extreme C-termini of proteins. A model based on microarray data has
been recently published for predicting the binding preferences of PDZ domains to five residue long C-terminal sequences.
Here we investigated the potential of this predictor for discovering novel protein interactions that involve PDZ domains.
When tested on real negative data assembled from published literature, the predictor displayed a high false positive rate
(FPR). We predicted and experimentally validated interactions between four PDZ domains derived from the human proteins
MAGI1 and SCRIB and 19 peptides derived from human and viral C-termini of proteins. Measured binding intensities did not
correlate with prediction scores, and the high FPR of the predictor was confirmed. Results indicate that limitations of the
predictor may arise from an incomplete model definition and improper training of the model. Taking into account these
limitations, we identified several novel putative interactions between PDZ domains of MAGI1 and SCRIB and the C-termini of
the proteins FZD4, ARHGAP6, NET1, TANC1, GLUT7, MARCH3, MAS, ABC1, DLL1, TMEM215 and CYSLTR2. These proteins are
localised to the membrane or suggested to act close to it and are often involved in G protein signalling. Furthermore, we
showed that, while extension of minimal interacting domains or peptides toward tandem constructs or longer peptides
never suppressed their ability to interact, the measured affinities and inferred specificity patterns often changed
significantly. This suggests that if protein fragments interact, the full length proteins are also likely to interact, albeit possibly
with altered affinities and specificities. Therefore, predictors dealing with protein fragments are promising tools for
discovering protein interaction networks but their application to predict binding preferences within networks may be
limited.
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Introduction
Many of the protein interactions that function in cellular
regulation and signalling are mediated by linear motifs that bind to
globular domains. Such interactions are often specific, yet
transient and therefore of low affinity [1]. The efficient prediction
of such interactions together with their experimental validation
would enormously increase our understanding of the cellular
system. The occurrence of specific types of globular domains in
protein sequences can mostly be predicted with high accuracy [2]
[3] and promising work on linear motif predictions are published
[4][5]. However, the correct prediction of which instance of a
linear motif will bind to which instance of a type of globular
domain, hence the specificity in domain - linear motif interactions,
remains one of the hot topics in computational biology.
Approaches for predicting domain-linear motif interactions
have very often focussed on PDZ-peptide interactions. PDZs are a
very abundant class of globular domains with 267 occurrences in
the human proteome [6]. Human proteins often contain several
copies of PDZs (up to 13) in their sequence. PDZs bind with a well
defined pocket to linear motifs that are mostly situated at the
extreme C-termini of proteins. The last residue (referred to as
position p0) in PDZ-binding motifs is usually Val or Leu. The
third last peptide residue (position p-2) can be either Thr or Ser
(class I), hydrophobic (class II), or Glu or Asp (class III), thereby
defining three main categories of PDZ-binding motifs [7][8]. 339
experimentally verified PDZ-peptide interactions are currently
annotated in the PDZbase [9] and 212 PDZ structures are listed in
the ADAN database [10] indicating that PDZs are very well
experimentally studied.
PDZs are implicated in the regulation of cell polarity, cell
adhesion and intercellular communication [11]. The PDZ-
containing proteins MAGI1 (Membrane-associated guanylate
kinase inverted 1) and SCRIB (human Scribble) are in the centre
of this study. MAGI1, which has six PDZ domains, was found to
be located to adherens and tight junctions in epithelial [12] and
endothelial cells [13], where it seems to be involved in the
maintenance of the junctions and in cell signal propagation.
SCRIB, which has four PDZ domains, is known to be involved in
the establishment of adherens [14] and tight junctions [15] as well
as in the regulation of cell polarity and cell migration [16]. Some
data indicate that deregulation of MAGI1 [17] or SCRIB [18] can
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proteins from different viruses were shown to bind via their C-
terminal sequences to MAGI1 or SCRIB and to interfere with
their cellular functions for promoting viral replication [19] [20].
For instance, the oncoprotein E6 produced by the human
papillomaviruses (HPV) responsible for cervical cancer contains
a PDZ-binding motif, which interacts with PDZ domains of
MAGI1 and SCRIB [21] [22]. Deletion of this motif in HPV16 E6
impaired its capacity to promote cancer in transgenic mice [23]
indicating that binding of E6 to MAGI1 and SCRIB might be
implicated in the development of cervical cancer. Therefore, it
would be important to better understand the signalling pathways,
such as those of cell growth and apoptosis, that are regulated by
MAGI1 and SCRIB and that are disrupted upon infection with
oncoviruses such as HPV.
Until recently, only specific case studies had been published on
the specificity of PDZ-peptide interactions, and the iSPOT tool
[24] was for a long time the only attempt to predict PDZ-peptide
interactions on a broader scale. In 2007 and 2008, two groups
published outstanding large-scale studies on PDZ interactions
providing insights into PDZ interaction specificities and strategies
for their prediction [25] [26] [27]. Tonikian et al. [25] applied
phage display to determine the binding profiles of 28 C. elegans and
54 H. sapiens PDZ domains using 10 billion random peptides.
Stiffler et al. [26] applied microarrays and fluorescence polarisation
to measure binding affinities between 157 mouse PDZ domains
and 217 mouse peptides. All interactions and non-interactions
(absence of interactions) determined by Stiffler et al. were used by
Chen et al. [27] as training data for a PDZ interaction predictor.
The prediction model was defined using the structure of the a1-
syntrophin PDZ domain bound to a seven residue-long peptide of
which five are visible in the structure [28]. The model consists of
38 position pairs of domain and peptide residues that were seen to
interact with each other in this particular structure. The training
data was used in a Bayesian approach to obtain sub-scores for the
occurrence of all possible combinations of amino acid pairs at
these 38 position pairs. These sub-scores quantify the positive,
neutral or negative contribution of a pair of amino acids at a
certain position to the overall interaction between a PDZ domain
and a peptide. The sum of the 38 sub-scores for a given PDZ-
peptide pair represents the final score, which was suggested to
indicate the binding strength of the potential interaction in
question.
A very critical point for the development of protein interaction
predictors is the availability of real negative interaction datasets
[29]. Stiffler et al. [26] provide a negative PDZ interaction dataset,
which has already been used to significantly improve PDZ
interaction prediction quality [30][31]. However, this negative
dataset is the only one existing so far, which implies that PDZ
interaction predictors trained with data of Stiffler et al. [26], such
as the predictor of Chen et al. [27], cannot be tested on an
independent negative dataset.
The numerous existing predictors for PDZ-peptide interaction
specificities focus on the core PDZ domain or binding pocket of
the PDZ and mostly on four or five residue long peptides [27] [30]
[31] [32] [33] [34] [35]. Generally, it is assumed that interaction
specificity predictions based on such protein fragments are also
valid in the context of full length protein interactions and hence
can be used to predict protein-protein interaction (PPI) networks.
However, an increasing amount of biological studies on PDZ
domains suggest that peptide residues upstream of the last five
residues and domain residues outside of the binding pocket
influence binding affinity and specificity [36] [37] [38] [39] [40].
Linker regions flanking the core PDZ domain as well as
neighbouring domains, have also been found to influence binding
[41] [42]. The term supramodule was introduced for neighbouring
PDZs that are separated by particularly short linker sequences and
that were shown to significantly influence each other’s peptide
binding (for a review see [43]).
Based on these observations, several questions are raised: First
of all, how correct are PDZ interaction predictors in theory and in
practice? Second, to which extent can specificity predictions based
on protein fragments be transferred to full length proteins and how
much influence do extensions of protein fragments have on affinity
and specificity of the corresponding interaction? Third, can
existing PDZ interaction predictors be used to extend our
knowledge on PPI networks mediated by PDZ-peptide interac-
tions? Here, we attempted to answer these questions by focussing
on the well studied predictor published by Chen et al. [27]. First,
we aimed at assessing its prediction quality in silico by using test
datasets assembled by ourselves that consisted of real positive and
negative interaction data for various PDZ domains. Then, by
concentrating on PDZ domains of MAGI1 and SCRIB, we
performed proteome-wide interaction predictions and experimen-
tally validated a subset of those, allowing us to also assess the
prediction quality in vitro. We also assessed how binding was
influenced by extended protein fragments, i.e. peptides and PDZ
constructs longer than those considered by the predictor. Finally,
discovered interactors for MAGI1 and SCRIB were analysed with
regard to new biological functions that can be linked to MAGI1
and SCRIB and that might be perturbed in tumours induced by
oncoviruses or other factors. In total, this analysis allowed to
highlight the power and limits of PPI network predictions
involving PDZ domains, to uncover possible ways of improve-
ments, and to obtain further insights into the mechanisms that
define affinity and specificity of PDZ-peptide interactions.
Results
Development of real negative test datasets for
benchmarking PDZ interaction predictors
We aimed at assessing the performance of the PDZ interaction
predictor published by Chen et al. [27] with independent datasets
of human PDZ-peptide interactions from low-throughput exper-
imental studies. We assembled three test datasets (see Dataset S1)
containing interactions and non-interactions involving 95 different
human PDZ domains. The first test dataset contained 174 PDZ-
ligand interactions including 109 human interactions from
PDZbase [9] (a resource of experimentally verified PDZ-ligand
interactions) plus 65 interactions that we manually collected from
literature, mainly dealing with PDZ domains from MAGI1, 2 and
3. The PDZ domains from MAGI1, 2 and 3 are identical between
human, mouse and rat when concentrating on the 16 domain
amino acid positions used for predictions by Chen et al. Therefore,
we included in the datasets interactions that we expect to occur
between human proteins although they were originally described
in the literature using rat and mouse PDZ domains.
The second and third test dataset contain negative interaction
data that were assembled from published literature as follows. We
took advantage of the particular characteristic of PDZ domains to
occur as repeats within proteins (as illustrated in Figure 1). In order
to experimentally determine the PDZ domain to which a peptide
will bind out of the PDZ domains of a particular protein, each
PDZ domain of the protein is tested separately for binding to the
peptide. This approach usually yields one genuine interaction and
many non-interactions. These non-interactions were annotated
into one negative test set that in total contained 446 human non-
interactions involving peptides bearing a PDZ-binding motif. The
Predicting PDZ-Motif Interactions
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from the literature where the peptide has a disrupted PDZ-binding
motif due to introduced mutations (substitutions or deletions).
These real negative experimental data can be expected, as argued
by Smialowski et al. [29], to outperform artificial negative data
(such as randomised protein interactions) in terms of training and
test performance.
Benchmarking the PDZ-ligand interaction predictor of
Chen et al.
When tested on the three established test datasets (Table 1) the
predictor of Chen et al. obtained a sensitivity of 75.3% in agreement
with that indicated by Chen et al. (76.5%) [27]. By contrast, the false
positive rate (FPR) based on non-interactions with PDZ-binding
motifs is about 48%, which is considerably higher than the FPR
indicated by Chen et al. (24%). Furthermore, the FPR obtained for
non-interactions without PDZ-binding motifs is about 26%, which
represents a weak performance with regard to the relatively
straightforward task to discriminate between peptides that bear a
prototypical PDZ-binding motif or not. We then analysed
separately, within our test datasets, the data involving human
PDZ domains that are either orthologous or not orthologous to the
mouse PDZ domains present in the training set of Chen et al.
Sensitivity and FPR of these subsets show that the predictor tends to
be over-optimistic for PDZ domains that are orthologous to
domains present in the training data, and over-pessimistic for
PDZ domains that arenot orthologous to anydomain present in the
training data (third and fourth column in Table 1).
Our test datasets contain a large portion of interactions and
non-interactions involving PDZ domains from MAGI1, 2 and 3.
We separately calculated the sensitivity and FPRs of the predictor
for subsets of the test datasets consisting only of PDZ domains of
MAGI1, 2 and 3 (fifth column in Table 1). The results are
considerably different from those obtained with the full datasets,
indicating that the MAGI subset does over-influence the
calculations.
Prediction of natural PDZ-peptide interactions using the
predictor of Chen et al.
The predictor of Chen et al. [27] was applied to PDZ domains of
MAGI1 and SCRIB (see Figure 1 for the domain organisation of
these proteins) with the aim of predicting, from the entire human
proteome, natural interacting partners for these PDZs. For most
domains, the numbers of predicted hits (proteins) were very high
(Table 2, second column). An important proportion of these hits
might be false positives in relation to the previously observed high
FPR (Table 1). Indeed, one third of the C-terminal sequences of
the returned hits had a non-hydrophobic amino acid at peptide
Figure 1. PDZ domains of MAGI1 and SCRIB. MAGI1 has 6 PDZ domains numbered from 1 to 6. SCRIB has 4 PDZ domains numbered from 1 to
4. The PDZ domains that were used for interaction measurements by SPR are highlighted in black and used domain boundaries are indicated.
doi:10.1371/journal.pone.0025376.g001
Table 1. Performance of predictor of Chen et al. for different
test data sets.
complete
test data training
a
non-
training
b MAGI1,2,3
c
sensitivity
d 75.3% (174) 90.7% (97) 55.8% (77) 65.9% (41)
FPR PDZ
e 48.2% (446) 53.5% (213) 43.3% (233) 17.5% (240)
FPR NoPDZ
f 25.6% (133) 27.6% (58) 24.0% (75) 4.0% (50)
atest data containing only (non)-interactions with PDZ domains orthologous to
those from the training data of Chen et al.
btest data containing only (non)-interactions with PDZ domains that were not
orthologous to those in the training data of Chen et al.
ctest data containing only (non)-interactions with PDZ domains from MAGI1, 2
and 3 proteins. These subsets were analysed to verify that the
overrepresentation of PDZ domains from these proteins did not introduce a
bias in calculated sensitivity and specificities.
dpercentage of interactions that were correctly predicted.
epercentage of non-interactions with PDZ-binding motif that were not correctly
predicted.
fpercentage of non-interactions without PDZ-binding motif that were not
correctly predicted.
The numbers in brackets represent the total number of items in the respective
test data set.
doi:10.1371/journal.pone.0025376.t001
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concerning PDZ-binding sequence requirements. We analysed
the amino acid composition of the pool of peptide sequences used
to train the predictor of Chen et al. (Table S1) and observed that
this pool of sequences had only V, L, I, F, C or A at position p0.
This is due to the fact that the entire training pool of Chen et al.
contained exclusively peptides that bound at least to one PDZ
domain in the experiments of Stiffler et al. [26] and hence
represent PDZ-binding sequences. In the training process, Chen
et al. allocated zero (representing a neutral value) to all amino acids
that were never seen at particular peptide positions. Whereas this
strategy is sound when applying the predictor to peptides matching
the general PDZ-binding consensus, it may lead to the selection of
irrelevant peptides when querying an entire proteome. To take this
issue into account, we applied an additional filter to accept only
peptides ending with either C, Y, F, L, I, M, V, W or A, i.e.
residues that were observed at position p0 in artificial or natural
PDZ-binding peptides. This filter rejected 20 to 60% of the initial
hits (Table 2, third column) and was systematically used further on
in our study. Detailed information on the predicted interactions is
provided in Dataset S2.
As shown in Table 2 (third column), some domains (e.g.
MAGI1-5/6 - the fifth out of six PDZ domains of MAGI1)
appeared to be very promiscuous as they had a very high number
of hits, whereas others (e.g. MAGI1-4/6) had very few hits or even
no hit at all (MAGI1-1/6). Within both MAGI1 and SCRIB, the
PDZ domains obtaining the highest numbers of hits (MAGI1-5/6,
2/6 and 6/6, and SCRIB-2/4 and 3/4) were also the ones that
obtained the highest scores (Table 2, fourth column). This might
be correlated with our observation that scores obtained by
different domains were distributed over different ranges
(Figure 2). While investigating why some domains (e.g. MAGI1-
5/6) showed higher scores and higher numbers of hits, we
observed that particular peptide residues contributed very high
subscores to the overall score for a domain-peptide pair. For
instance, the occurrence of a Thr at position p-2 (a characteristic
common to all class I PDZ-binding motifs) contributed a value of
0.64 to the prediction score for binding to MAGI1-5/6, while the
overall value sufficient for a peptide to be classified as a hit by the
preditor is 0.5. This means that any peptide possessing a Thr at
position p-2 and residues at other positions that confer a predicted
globally neutral effect for binding, would be classified as a binder
for the MAGI1-5/6 domain. At present, we do not know whether
this characteristic of MAGI1-5/6 is biologically meaningful or
whether it just reflects some bias of the predictor’s algorithm.
Indeed, the predictions differ from published biological data
(Table 2, fifth column), which indicate that the PDZ domain of
MAGI1 attracting most binders is MAGI1-6/6, rather than
MAGI1-5/6.
We also observed (Table S2) that numerous proteins were
predicted to bind to more than one PDZ domain of MAGI1 or
SCRIB, indicating that not only PDZ domains, but also C-
terminal peptides, are considered to be promiscuous by the
predictor. This may just originate from the lack of specificity of the
predictor as already pointed out before in our analysis (see
Table 1). However some PDZ-peptide interactions may indeed be
really promiscuous and the predictor may be able to detect this
trend.
Structure-based analysis of domain amino acid positions
implicated in peptide binding
In the prediction model of Chen et al. 16 domain and 5 peptide
positions were selected for being implicated in specific binding of
peptides to PDZs. This selection was based on one structure, a1-
syntrophin [28] (Figure 3). The structural information on PDZs
has considerably grown during the last years mainly due to
structural genomics initiatives. Here, we comparatively analysed
42 structural complexes of 24 different PDZ domains to get a more
general overview about amino acids involved in peptide
recognition. Figure 4 shows that the set of domain amino acids
found at less than 5 A ˚ from the peptide in the various structures
we analysed often differs from the set defined by Chen et al. in the
structure of a1-syntrophin (these positions are indicated with
asterisks above the alignment). For instance, domain positions
Leu37 (a1 helix) and Thr74 ( a2–b5 loop) in a1-syntrophin
(Figure 4), chosen by Chen et al., were only selected once in the 23
other PDZ domains we analysed. Conversely, our approach (see
Methods) selected more amino acids on a2 helix. In addition,
while Chen et al. did not select any amino acid upstream of the
GLGF-motif, our approach often selected residues in that region,
especially a conserved positively charged position (Arg or Lys)
within the b1-b2 loop. The role of this amino acid for peptide
binding is discussed in several studies [44] [45] [46]. Finally, our
Table 2. Numbers of human proteins predicted to bind to PDZ domains of MAGI1 and SCRIB using the predictor of Chen et al.
PDZ domain unfiltered hits filtered hits
a
num. prots. with
highest score
b num. publ. binders
c
MAGI1-1/6 0 0 0 1
MAGI1-2/6 457 300 93 4
MAGI1-3/6 160 107 0 1
MAGI1-4/6 43 30 0 3
MAGI1-5/6 1151 623 562 3
MAGI1-6/6 219 179 87 6
SCRIB-1/4 204 89 1 4
SCRIB-2/4 429 203 98 1
SCRIB-3/4 744 293 237 5
SCRIB-4/4 354 113 3 1
aproteins without residue C, Y, F, L, I, M, V, W or A at peptide position p0 were filtered out.
bnumbers of proteins, which were predicted (after filtering) to bind to that domain and scored highest for that domain in comparison to the other domains.
cnumbers of published mammal binders that we could identify from literature for each PDZ domain.
doi:10.1371/journal.pone.0025376.t002
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one residue of that loop was selected in Chen et al.’s study. The
selection of residues of the b2-b3 loop indicates that residues
upstream position p-4 are proximal to this loop and therefore may
also contribute to binding (Figure 3). Altogether, we suggest that
more domain and peptide positions than those defined by Chen
et al. may influence binding specificity.
Experimental validation of predicted MAGI1-peptide and
SCRIB-peptide interactions
From predictions obtained with the predictor of Chen et al. we
selected 17 human and three viral peptides for interaction
measurements against five PDZ constructs: the four single PDZ
domains MAGI1-2/6, MAGI1-3/6, SCRIB-3/4, SCRIB-4/4,
and the tandem construct SCRIB-34/4 (Figure 1). The 17 human
peptides were selected based on different criteria: First, we selected
peptides that were predicted to bind promiscuously to all four
single PDZ domains. Second, we systematically included the two
best predicted hits for each of the four PDZ domains. Third, we
preferred proteins already shown to interact with PDZ domains.
Further selection criteria were sequence diversity within the set of
selected peptides and biological functions related to known
functions of MAGI1 and SCRIB. These were inferred from Gene
Ontology annotations (Ensembl v52 [47]) and information
provided by UniProt [48]. The three viral peptides correspond
to the C-terminus of HTLV1 Tax1, HPV16 E6, and a mutated
form of HPV16 E6 (further on called 16E6L/V), where Leu at
position p0 was mutated to Val. The latter peptide was already
assayed against MAGI1 and SCRIB PDZ domains in previous
SPR studies performed by our group, and therefore we used it as
positive control for the present study. Table S3 provides detailed
information about the 19 proteins.
For each of these 19 proteins two peptides were designed, both of
ten amino acids in length. One peptide, called ‘‘long’’, encompassed
the last ten wild type residues of the protein (e.g. VMRLQSETSV
for VANG2). The other peptide, called ‘‘short’’, encompassed the
last five wild type amino acids of the protein preceded by a
GSGAG sequence (e.g. GSGAGSETSV for VANG2). This
GSGAG sequence, composed of small neutral residues, was
included to prevent the biotin tag N-terminally attached to the
peptides to influence the binding to the PDZ domain. The ‘‘short’’
peptides, in which only the last five residues vary and correspond
to natural proteins, would allow us to experimentally validate
interaction predictions obtained with the predictor of Chen et al.
that considers the last five residues in the prediction model. The
long peptides (as well as the tandem PDZ construct) would allow
us to address changes in binding affinity and specificity that might
occur when using extended protein fragments.
We opted for the surface plasmon resonance (SPR) method to
measure these 190 (19 proteins62 peptide versions65 PDZ
constructs) interactions. In SPR various concentrations of
‘‘analytes’’ (here, PDZ domains fused to the Maltose Binding
Protein (MBP)) flow over surfaces presenting attached ‘‘ligands’’
(here, biotinylated peptides). The amount of analyte interacting
with the ligand is measured and quantified in response units (RU).
The intensity of this signal is proportional to the binding strength
of the assayed interaction (Figure 5A). KD were obtained using a
1:1 interaction model. However, these calculated KD were rather
inaccurate especially for weak interactions. Therefore, we
Figure 2. Score distribution of human C-terminal peptides predicted to bind to MAGI1 PDZ domains. Predictions were prefiltered for
peptides having either C, Y, F, L, I, M, V, W or A at peptide position p0. Prediction scores were rounded to two decimal places and the frequencies of
occurrence of scores within each interval were determined for each PDZ domain of MAGI1.
doi:10.1371/journal.pone.0025376.g002
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using normalised RU signals at equilibrium (Req) rather than KD
(see Methods for details). These normalised Req values were
plotted in form of a heat map (Figure 5B). Table S4 contains
experimental data for all SPR measurements performed in this
study.
Nine out of nine published interactions (including 16E6L/V)
were confirmed by our experimental data, of which three out of
four published KD could be confirmed as well, all being high
affinity interactions (see Table S3 for more details). This
demonstrates the validity of our experimental SPR setup for
testing PDZ-peptide interactions.
Peptides do not bind as promiscuously as predicted to
PDZ domains
Most tested peptides had been predicted to bind promiscuously
to all four single PDZ domains (see Figure 5B, zeros indicate the
very few PDZ-peptide pairs predicted not to interact). In practice,
the peptides turned out to be much more selective than predicted.
Only one peptide, TAX1 (derived from a viral protein), was found
to interact with the four PDZ domains, and only at the condition
of taking a very weak interaction into account. Even when we
discarded the SCRIB-4/4 domain (which bound only one peptide
as will be discussed later), we observed that, out of the 16 peptides
predicted to bind the remaining three single PDZ domains, only 8
could be confirmed (see Figure 5B, underlined peptide names),
again only at the expense of accepting very low interaction signals.
This appears to confirm the high false positive rate of the predictor
of Chen et al. that we have previously noticed (Table 1).
The prediction scores do not correlate with interaction
affinities
Chen et al. have observed a correlation between prediction
scores and binding affinities. In our set of data (19 short peptides
vs. 4 single PDZ domains), we did not observe such correlation (for
MAGI1-2/6 Pearson correlation coefficient r=0.44 p-val-
ue=0.07, for MAGI1-3/6 r=0.13 p-value=0.64, for SCRIB-3/
4 r=0.1 p-value=0.69, for SCRIB-4/4 r=20.08 p-value=0.74)
(Figure 6). In particular, the two best predicted hits for each PDZ
domain turned out to be non-interactions or very weak
interactions in all cases except one (Figure 5B, rectangles).
SCRIB-4/4 may display very specific binding preferences
SCRIB-4/4 was found to significantly bind to only one peptide,
TAX1, despite of the fact that SCRIB-4/4 was predicted to bind
to 15 out of the 19 peptides tested (Figure 5B). Remarkably, Zhang
et al. [49] previously noticed that the SCRIB-4/4 domain did not
bind any peptide in a phage display experiment. They interpreted
this observation by suggesting that recombinant SCRIB-4/4 might
be less stable than other PDZ domains. This possibility can be
excluded, since we produced highly concentrated folded SCRIB-
4/4 for NMR studies (data not shown), and the NMR structure of
folded SCRIB-4/4 was solved by the RIKEN Structural
Genomics Initiative (PDB code: 1UJU). We suggest that SCRIB-
4/4 displays very specific peptide binding preferences, which can
be inferred from analysis of available protein structures. We
retrieved from the PDB the experimental structures of MAGI1-2/
6, MAGI1-3/6 and SCRIB-4/4, and modelled the structure of
SCRIB-3/4 (see Methods). The surface electrostatics representa-
tions of the four PDZ domains (Figure 7A) show that, in
comparison to the other three PDZ domains, SCRIB-4/4
possesses many positive charges surrounding the peptide binding
pocket. This should favour peptide sequences with negatively
charged residues at position 21 and 23.
The ‘‘GLGF-loop’’, which precedes the b2 strand, coordinates
the C-terminal carboxyl group of the peptide and also influences
the width of the pocket accomodating the hydrophobic residue at
p0 [45]. The first glycine of the ‘‘GLGF-loop’’ is replaced by a
bulky arginine residue in SCRIB-4/4 (Figure 7B). This may
sterically prevent binding of a peptide presenting a large
hydrophobic side chain at p0 and might explain the shallow
appearance of the pocket accommodating the peptide residue p0
(Figure 7A). These size and charge constraints may impose
sequence properties only found in TAX1 (ETEV) out of the 19
peptides tested.
Different preferences of PDZ domains for residues at
peptide position p0
Our interaction data reveal different binding preferences of the
PDZ domains for specific hydrophobic amino acids at peptide
position p0 (Figure 5B and Figure 8, see green residues at p0 in
peptide sequences). SCRIB-3/4 seems to accept larger hydropho-
bic residues at p0 with a preference of leucine over valine. Indeed,
SCRIB-3/4 binds stronger to wild type 16E6 as compared to the
Figure 3. Structure of the PDZ domain of a1-syntrophin used as
reference by Chen et al. Residues coloured in blue represent the
domain positions that are considered in the prediction model of Chen
et al. The backbone and Cb atoms of the bound peptide are
represented as sticks in pink. The pink dashed line indicates where
peptide residues upstream position p-4 would be situated in the
structure. (PDBcode: 2PDZ).
doi:10.1371/journal.pone.0025376.g003
Predicting PDZ-Motif Interactions
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e25376single mutant 16E6L/V, where the last residue of 16E6 has been
mutated from leucine to valine. In contrast, MAGI1-2/6 binds
stronger 16E6L/V than wild type 16E6, showing that MAGI1-2/6
preferentially accommodates valine in comparison to leucine. This
was also observed by Thomas et al. [50] using full length E6
proteins. MAGI1-3/6 only accepts valine.
These different preferences for amino acids at p0 might be again
correlated with amino acid variations in the conserved ‘‘GLGF-
loop’’. The alignment in Figure 7B shows that the two conserved
hydrophobic positions of the ‘‘GLGF-loop’’ are occupied by
phenylalanine residues in both MAGI1-2/6 and MAGI1-3/6 vs.
two leucine residues in SCRIB-3/4. This might contribute to a
wider pocket in SCRIB-3/4, explaining the preference of this
domain for a C-terminal leucine in the bound peptide.
These different preferences for residues at p0 were only partially
correctly predicted for MAGI1-2/6 and MAGI1-3/6 by the
predictor of Chen et al. The predictor failed to predict these amino
acid preferences for SCRIB-3/4 (see Dataset S2).
Binding affinities and specificities change for extended
interaction fragments
We observed that the tandem construct SCRIB-34/4 bound
several peptides with higher affinity as compared to the single
domain constructs SCRIB-3/4 and SCRIB-4/4 (Figure 5B). This
increase seemed not to depend on the sequence of the peptides.
In addition, we observed that the long peptides often bound
PDZ domains with different affinities as compared to the short
peptides (Figure 5B). As highlighted in Figure 3, the additional
wild type residues present in the long peptides, upstream position
p-4, are likely to engage interactions with residues in the b2-b3
loop of the PDZ domains. Figure 8 shows part of the structures of
the PDZ domains MAGI1-2/6, MAGI1-3/6 and SCRIB-3/4
comprising the region, where the b2-b3 loop is situated (see
Figure 7B for an alignment). Next to the structures, the differences
in RU signals between long and short peptides are ranked from the
greatest difference to the lowest. MAGI1-2/6 has four negatively
charged residues in the b2-b3 loop and shows strong increases in
affinity for long peptides having positively charged residues at
peptide positions upstream p-4. The closer these positively charged
residues are positioned to p-4, the bigger is the increase in affinity
for long versions of peptides. By contrast, negative charges at these
peptide positions appear to be disadvantageous (Figure 8A).
MAGI1-3/6 did not show significant differences in affinity and
specificity between short and long peptides. This observation may
be explained by the fact that the b2-b3 loop contains four
consecutive glycine residues unlikely to influence peptide binding
(Figure 8B). SCRIB-3/4 shows an unspecific increase in affinity for
many long peptide versions. The b2-b3 loop of SCRIB-3/4 is
twice as long as for the other two PDZ domains and contains
amino acids of diverse physico-chemical properties (Figure 8C).
This loop might be able to adapt conformationally to many
different sequences upstream of peptide position p-4, therefore
providing advantageous contacts in most cases.
Discussion
In this study we addressed the problem of predicting naturally
occurring protein interactions mediated by PDZ domains and
PDZ-binding peptides using the predictor of Chen et al. [27]. We
analysed the predictor using theoretical and practical approaches.
An important step for a fair assessment of prediction qualities is the
application of real test datasets independent from the training
data. To ensure this, we assembled a novel dataset of real negative
PDZ-peptide interactions from the literature, which might turn
out to be very useful for further development of PDZ interaction
predictors.
Both the in silico and in vitro tests indicated that prediction
accuracies were weak. We could demonstrate that the predictor of
Figure 4. Atomic distance-based selection of peptide-contacting domain positions in different PDZ-peptide structures. For each PDZ
domain of the alignment, we extracted from available structural data all domain residues that had at least one atom within a distance of 5 A ˚ to
bound peptide atoms. Blue letters indicate residues, which have been selected both, by Chen et al. and our approach. Red letters indicate residues,
which have been selected by our approach but not by the model of Chen et al. Asterisks above the alignment indicate the PDZ residues chosen by
Chen et al. to be close to peptide residues based on the structure a1-syntrophin (SNTA1, first line of alignment). Arrows and rectangles above the
alignment indicate the positions of conserved b-sheets and a-helices, respectively. Note that the sequence of the Par6 PDZ domain occurs twice in
the alignment, corresponding to two different structures of Par6, one bound to an internal peptide, the other one bound to a regular C-terminal
peptide.
doi:10.1371/journal.pone.0025376.g004
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Bader [30] and that predictions are biased towards the training
interaction data. Prediction scores seemed not to correlate with
interaction affinities, and amino acid preferences at peptide
position p0 were only partially correctly predicted. These
limitations may result from both an incomplete model definition
and inadequate training of the model. Regarding model definition,
we showed that PDZ domains display significant structural
variation, so that the model of Chen et al., which is based on a
single PDZ-peptide structure, may have excluded residues that are
important for peptide binding. Regarding model training, the
interaction dataset of Stiffler et al. [26] provided values for only
about one third of the vast number of the model’s parameters
(20620638=15200). The other two thirds of the parameters were
given by default the value zero, assuming that they are neither
positively nor negatively contributing to PDZ-peptide interaction
affinities. This allowed in particular for the tolerance of
disadvantageous amino acids or over-weighting of advantageous
yet non-specific residues in peptides and PDZ domains. This
problem was intensified by the fact that the negative training data
Figure 5. Overview of SPR experimental data. A: Representative sensorgrams for strong and weak interactions as well as non-interactions. An
increase of the signal for injection of MBP-PDZ analyte is indicative of binding. (i) The higher the analyte concentration, the higher the Req up to
saturation, indicative of a specific interaction. (ii) For weak interactions the highest analyte concentration, which was injected due to device
limitations, did not allow to reach saturation. (iii) Sensorgrams for non-interactions display no change in signal. B: Overview of measured RU signals
and comparison to predictions. Normalised RU signals determined for a 10 mM concentration of MBP-PDZ were extracted from SPR sensorgrams and
plotted as heatmap for 19 peptides in short and long versions vs. the five PDZ constructs MAGI1-2/6, MAGI1-3/6, SCRIB-3/4, SCRIB-4/4 and SCRIB-34/4.
An approximate range of KD is indicated at the right side of the heatmap. 05 and 10 indicate short and long versions of peptides, respectively.
ND=not determined. Signals of short peptides interacting with single PDZ constructs were compared to interaction predictions performed with the
predictor of Chen et al. [27]. Rectangles and dashed rectangles indicate the first and second best hit for each PDZ domain, respectively, out of a
proteome-wide screen. PDZ-peptide pairs that were predicted not to interact are labelled with zero. All other pairs of short peptides and single PDZ
constructs were predicted to interact. Peptide names that are underlined indicate short peptides that were predicted and confirmed experimentally
to bind to at least three of the four single PDZ domains. 16E6L/V served as control.
doi:10.1371/journal.pone.0025376.g005
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limiting again the sequence space covered. To turn around these
limitations, it might be relevant to reduce the number of
parameters that have to be trained by grouping amino acids
according to their various physico-chemical properties [51].
Additionally, a filter should be applied that removes all predicted
interactions with very unlikely PDZ-binding sequences, as has
been done in the present study.
The predictor of Chen et al. is based on minimal interacting
fragments corresponding to single PDZ domains and five residue-
long peptides. We investigated how extensions of these minimal
fragments would influence binding. The peptides that showed
binding to SCRIB-3/4 generally displayed an increase in binding
affinity in the presence of the tandem construct SCRIB-34/4.
Since the isolated SCRIB-4/4 domain hardly bound to any
peptide, we hypothesise that SCRIB-4/4 contributed indirectly to
the increase in affinity of the SCRIB-3/4 domain for its target
peptides, maybe by stabilising its structure. Such a long range
effect might be favoured by the fact that the linker sequence
between the two domains is particularly short (around 10 residues).
These observations indicate that SCRIB-34/4 may represent a
supramodule as defined by Feng and Zhang [43]. In a recent
structure-function study, we have also demonstrated that the
affinity of the MAGI1-2/6 PDZ domain to its peptidic target is
modulated by the sequence of the C-terminal flanking region of
the core structure of the PDZ domain [41].
Analysis of structures of PDZ-peptide complexes from the PDB
showed that peptide residues upstream of p-4 are proximal to the
b2-b3 loop of PDZ domains, and SPR measurements showed that
the same residues modulated binding. These observations confirm
previous findings [36] [37] [38] [39] [40]. Moreover, we observed
that the b2-b3 loop of different PDZ domains can display very
different effects on affinity and specificity of peptide binding. The
observation that flanking sequences surrounding a motif modulate
its interactions with the target domain may also account for other
classes of domain-peptide complexes [52].
Taken together, our results suggest that extensions of protein
fragments may lead to changes in affinity and specificity. However,
when comparing binding intensities obtained for long versus short
peptide constructs or for single versus tandem PDZ domains,
protein fragment extensions were never found to change an
experimentally significant interaction into a non-interaction, nor
vice-versa. Therefore, we hypothesise that whenever an interaction
is detected between minimal fragments, it is likely that the full
length proteins will also interact, albeit possibly with different
affinities. Unfortunately, affinity measurements could not be
undertaken with full length proteins to provide more evidence
for this hypothesis due to experimental limitations in handling
large proteins in vitro.
Our experimental data showed that many peptides bound
weakly, with affinities much weaker than 20 mM, to several of the
PDZ domains tested. These observations are consistent with
results of Wiedemann et al. [53], who predicted that for a KD
cutoff as low as 50 mM, hundreds of ligands would bind to three
distinct PDZ domains with largely overlapping specificity ranges.
It is often stated that interactions stop to be biologically relevant
when their affinity dissociation constants exceed a given threshold
(e.g. 100 mM). Such statements may have to be reconsidered when
dealing with affinities determined from protein fragments, such as
PDZ-peptide interactions, because as our data indicates, weak and
promiscuous interactions might become stronger and more
specific when moving from short protein fragments towards full
length proteins.
Based on the results presented here we suggest FZD4,
TMEM215 and ARHGAP6 as new interactors for MAGI1;
TANC1, GLUT7, DLL1, MAS and NET1 as new interactors for
SCRIB; and ABC1, MARCH3 and CYSLTR2 as new interactors
for both MAGI1 and SCRIB. Remarkably, several of these
Figure 6. Comparing predicted to measured interaction intensities. The measured interaction intensities (in RU) between short versions of
peptides and the PDZ domains MAGI1-2/6, MAGI1-3/6, SCRIB-3/4 and SCRIB-4/4 were plotted against the prediction scores obtained for the PDZ-
peptide pairs with the predictor of Chen et al. The prediction scores did not correlate with measured signals. Note that SPR measurements were
mostly performed for PDZ-peptide pairs that were predicted to bind to each other, explaining why the left region of the graph is empty.
doi:10.1371/journal.pone.0025376.g006
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TMEM215, GLUT7, ABC1, MARCH3, MAS, CYSLTR2,
DLL1) while the three remaining ones (ARHGAP6, TANC1,
NET1) are involved in activities localised to the membrane.
Indeed, SCRIB and MAGI1 were already known to localise to the
membrane where they interact with numerous proteins involved in
signal transmission, and more particularly in G protein mediated
signalling. On the one hand, MAGI1 had been shown to interact
with NET1 [54] [40], a guanine nucleotide exchange factor (GEF)
specific for the small G protein RhoA, as well as with PDZ-GEF1
[55], another GEF specific for the small G proteins Rap1A,
Rap1B and Rap2B. MAGI3, a close paralog of MAGI1, has been
shown to interact with the G protein coupled receptors (GPCRs)
FZD4 [56] and LPAR2 [57], and to interact with the integral
membrane protein VANG2 leading to the activation of the JNK
pathway via the small G protein Rac [56]. On the other hand,
SCRIB had been found to interact with two GEFs, bPIX [58] and
ARHGEF16 [49], leading to activation of the small RhoA family
G proteins Rac1 or Cdc42 [59] [60]. SCRIB has also been shown
to interact with TSHR (a GPCR) [61].
In line with these published findings, several of the novel
putative interactors of MAGI1 and SCRIB that we identified are
also involved in G protein signalling. FZD4, CYSLTR2 and MAS
are GPCRs; NET1 is a GEF; ARHGAP6 is a GAP (G protein
activating protein); ABC1 is a membrane transporter known to
recruit two GEFs (PDZRhoGEF and LARG) involved in Cdc42
and RhoA signalling [62] [63]. Therefore, our data reinforce the
view that MAGI1 and SCRIB act as scaffolds that assemble
proteins close to membranes to regulate G protein signalling. A
remarkable instance is MAGI1 which, as indicated by our data,
might be able to recruit simultaneously, via neighbouring PDZ
domains, a GEF (NET1) and a GAP (ARHGAP6) that are both
specific for the small GTPase RhoA, while possessing inverse
enzymatic activities (Figure 9).
MAGI1 and SCRIB are known to participate to the regulation
of neuronal synapses via interaction with numerous proteins [64]
[60] [65] [66]. Accordingly, TANC1, which was in our hands the
strongest cellular binder of SCRIB, is a scaffold component
protein in post-synaptic density regions [67]. Some other
interactions suggested by our work seem to provide novel links
between MAGI1 and SCRIB and pathways in which they were
not yet known to participate: Wnt/JNK pathway regulation
(FZD4), Notch pathway regulation (DLL1) [68], immune response
(CYSLTR2) [69], iron uptake (MARCH3) [70], blood vessel
regulation (MAS) [71], glucose transport (GLUT7) [72]. These
new interactions can provide interesting starting points for
exploration of potential new in vivo functions of MAGI1 and
SCRIB that might be perturbed upon infection with HPV.
In this work, we showed that inferring protein interaction
networks from predictions based on interacting protein fragments
should involve at least two very distinct steps. The first step
requires accurate prediction of interactions between the isolated
protein fragments considered by the predictor. The predictor we
used here for completing this step turned out to be rather
inaccurate. There is much room for improving this step, in
particular by integrating the wealth of structural information
recently accumulated about protein domains, especially PDZs.
The second step requires correct extrapolation of predicted
fragment interactions to interactions between full length proteins.
Our data indicate that such an extrapolation may be possible
qualitatively, but not necessarily quantitatively. Therefore, while
inferring protein interaction networks from minimal interacting
fragment predictions appears as a reasonable perspective, more
refined predictions addressing binding specificities in these
networks remain a challenging, yet fascinating prospect.
Materials and Methods
The programming and data analysis was done using python
(www.python.org), biopython [73], gnuplot (www.gnuplot.info)
and PyMOL (www.pymol.org). We used the same human
proteome as described in Luck et al. [74] to perform the
proteome-wide screens in this study.
Figure 7. Structural particularities of SCRIB-4/4 in comparison
to the three PDZ domains MAGI1-2/6, MAGI1-3/6, and SCRIB-3/
4. A. The three experimental structures and one model (SCRIB-3/4) are
shown in surface representation with red and blue indicating the
electrostatic potentials. The structures are displayed in the same
orientation as the PDZ domain in Figure 3. The peptide that was
crystallised in complex with MAGI1-2/6 is shown in black. (PDB codes:
2I04, 3BPU, 1UJU for MAGI1-2/6, MAGI1-3/6, and SCRIB-4/4, respectively.
The structure of SCRIB-3/4 was modelled from that of DLG4-1/3 (2KA9)
using Modeller [79].) SCRIB-4/4 has a particularly positively charged
surface around the peptide binding pocket in comparison to the other
three domains. In addition, the pocket accommodating the hydropho-
bic residue at peptide position p0 is particularly shallow in SCRIB-4/4.
These characteristics may explain the high ligand specificity displayed
by SCRIB-4/4. B. Extract of the sequence alignment of the four PDZs
illustrating differences within the GLGF-loop and the b2-b3 loop. SCRIB-
4/4 presents a bulky R residue instead of a G in the GLGF-loop probably
reducing the available space within the pocket.
doi:10.1371/journal.pone.0025376.g007
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PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e25376Figure 8. Influence of the b2-b3 loop of PDZ domains on peptide binding. Columns indicate from left to right the names of the peptides,
their sequences, the interaction intensities in RU for peptides with five and ten wildtype residues, and the interaction intensity difference between
both. Peptides with five wildtype residues had the five N-terminal residues replaced with GSGAG. For each PDZ the part of the structure containing
the b2-b3 loop is shown with loop side chains represented as sticks. Amino acids in the sequences and structures are coloured as follows:
red=negative charge, blue=positive charge, yellow=polar, green=hydrophobic. A. MAGI1-2/6 binds with increased affinity to peptides with
positive charges upstream p-4 probably due to four negative charges in the loop (pdb code: 2I04). B. MAGI1-3/6 does not show any difference in
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We assessed the performance of the predictor of Chen et al. [27]
by applying the commonly used measures Sensitivity (SE) and False
Positive Rate (FPR) of the ROC analysis. Here, the sensitivity is
defined as the percentage of PDZ-peptide interactions that were
correctly predicted (=True Positives (TP)) and is calculated as
follows:
SE~
TP
TPzFN
:100 ð1Þ
where FN specifies the number of False Negatives (PDZ-peptide
interactions not correctly predicted). The False Positive Rate is
defined as the percentage of PDZ-peptide non-interactions that
were not correctly predicted (=False Positives (FP)) and is
calculated as follows:
FPR~
FP
TNzFP
:100 ð2Þ
where TN specifies the number of True Negatives (PDZ-peptide
non-interactions correctly predicted).
Implementation, test, and application of the predictor of
Chen et al.
Chen et al. [27] trained the predictor in two different ways,
called the binary and affinity mode, of which each of them can be
used separately to apply the predictor. For the binary mode the
affinity to short and long peptides, possibly due to four ‘‘neutral’’ glycines in the loop (pdb code: 3BPU). C. SCRIB-3/4 shows rather an unspecific
increase in affinity for long peptides. The loop is very long and contains residues of all physico-chemical types.
doi:10.1371/journal.pone.0025376.g008
Figure 9. Suggested model for MAGI1 scaffolding function in Rho GTPase mediated signalling. Our data showed that PDZ2 and PDZ3 of
MAGI1 bind preferentially to the C-termini of NET1 (green) and ARHGAP6 (red), respectively. NET1 is a guanine nucleotide exchange factor (GEF),
which transfers a phosphate group (PO 3{
4 ) to the small GTPase RhoA, which in its GTP-bound form (yellow) is predominantly associated with the
membrane and stimulates downstream signalling pathways. ARHGAP6 is a GTPase-activating protein (GAP), which induces RhoA to release a
phosphate group, resulting in the shutdown of RhoA signalling. Inactivated GDP-bound RhoA (blue) is mostly present in the cytoplasm. This indicates
that MAGI1 recruits, via two adjacent PDZ domains, one activator and one inhibitor of the RhoA signalling pathway. Remarkably, the four last residues
of the two proteins NET1 and ARHGAP6 are identical, hence the distinct binding preferences of the two C-terminal peptides for PDZ2 and PDZ3 must
be defined by residues upstream.
doi:10.1371/journal.pone.0025376.g009
Predicting PDZ-Motif Interactions
PLoS ONE | www.plosone.org 12 November 2011 | Volume 6 | Issue 11 | e25376predictor was trained without consideration of measured binding
affinities (e.g. the training data was simply split into interactions
and non-interactions). In the affinity mode, binding affinities were
directly included in the training process. For all predictions
performed in this study, the binary mode was used. No
information about performance qualities was provided by Chen
et al. for the affinity mode. We performed a comparison of both
modes that revealed extremely different predictions with the
binary mode providing more reliable results (data not shown). The
predictor returns a score for each PDZ-peptide pair, which can be
used to estimate the likeliness that the PDZ domain will bind the
respective peptide. The higher the score, the more likely the
interaction. Here, we used a score cutoff of 0.5, which should yield
a sensitivity of 76% and FPR of 24% as specified by Chen et al.
Each of the 95 human PDZ domains in the test datasets were
added to the alignment of mouse PDZ domains provided by Chen
et al. in order to define the 16 amino acid positions on which
predictions are based. Mafft [75] was used to obtain a preliminary
alignment, which was corrected manually using Jalview [76] and
structural information, if available. The alignment is provided in
Dataset S3.
The training set containing 93 peptides of Chen et al. was not
provided in the publication. The set of peptides from the training
data was reconstructed as described by Chen et al. taking every
peptide that was seen at least once in an interaction with a PDZ
domain in the experimental data obtained by Stiffler et al. [26].
This revealed 108 peptides.
In Text S1 and Dataset S4 we provide guidelines and
programming code, respectively, for users of the predictor of
Chen et al., who wish to follow our developed protocol.
PDZ pocket analysis
Available structures of PDZ-ligand complexes were analysed in
order to assess important domain residues for ligand recognition.
A keyword search with ‘‘PDZ’’ in the PDB [77] revealed 267
structures. Crystal structures were excluded, if the PDB files did
not contain coordinates of the full complex but just of one chain
(e.g. PDB code 2EGN). After manual inspection, a final set of 42
structures with PDZ-peptide complexes was retained for further
analysis representing 24 unique PDZ domains. For each PDZ
domain all structural models obtained by NMR and all complexes
shown in the crystal obtained by X-ray were taken into
consideration for the determination of all domain residues that
are in close proximity to bound peptides. A domain-peptide
residue pair was only accepted, if in all complexes of this particular
PDZ domain the distance between the two amino acids was in
average below a defined threshold. Three different distance
measures were implemented: Ca distances, distances between
residue’s centre of mass, and minimal atom distances between
residues. Different thresholds were tested from 0 to 40 A ˚. The
distance measure and cutoff that represented best the selection of
the 16 domain amino acids in a-syntrophin of Chen et al. [27] was
chosen: minimal atom distance with a threshold of 5 A ˚.
The PDZ sequences shown in Figure 4 were extracted from the
following PDB entries and chains: SNTA1_1/1 (2PDZ A),
AFAD_1/1 (2AIN A), APBA1_1/2 (1U38 A), ARHGC_1/1
(2OS6 A), DLG1_2/3 (2AWW A), DLG1_3/3 (2I0I C),
DLG4_3/3 (1TP5 A), EM55_1/1 (2EJY A), GRIP1_1/7 (2QT5
A), GRIP1_6/7 (1N7F B), HTRA1_1/1 (2JOA A), INAD_1/5
(1IHJ A), LAP2_1/1 (1N7T A), MAGI1_2/6 (2KPL A),
NOS1_1/1 (1B8Q A), PAR6_1/1 (1RZX A), PAR6i_1/1 (1X8S
A), PARD3_3/3 (2K20 A), PICK1_1/1 (2PKU A), PTN13_2/5
(1D5G A), RIMS1_1/1 (1ZUB A), SHAN1_1/1 (1Q3P B),
TIP1_1/1 (3DIW A), SYNT1_1/2 (1W9E A), SYNT1_2/2
(1V1T A).
Structure modelling
The structure of the PDZ domain SCRIB-3/4 was modelled
using the program Modeller 9v7. The structure template was
obtained by querying the PDB with the sequence of SCRIB-3/4
(using the BLAST option) and choosing the structure with the best
sequence match (PDZ domain DLG4-1/3, PDB-code 2KA9, 45%
sequence identity, e-value 1.0E-11). Modeller was run using the
automodel routine and default options. Model quality was assessed
using the output information of Modeller and visual inspection. A
model of SCRIB-3/4 of intermediate quality was sufficient for the
purpose of this study.
cDNA constructs
The cDNA encoding residues 448–572 and 613–752 of mouse
MAGI-1 (UniProt acc.: Q6RHR9-1) encoding for MAGI1-2/6
(100% identical to human MAGI1-2/6) and MAGI1-3/6 (99%
identical to human MAGI1-3/6) PDZ domains, respectively, were
inserted into the NcoI/KpnI sites of the pETM-41 expression
vector (EMBL) containing a 66His-MBP tag followed by a TEV
protease cleavage site. A similar cloning strategy was adopted for
cDNA bearing residues 997–1093, 1097–1193 and 997–1193 of
human SCRIB (Uniprot acc.: Q14160-1) encoding for SCRIB-3/
4, SCRIB-4/4 PDZ domains and SCRIB-34/4 tandem PDZ
construct, respectively.
Protein sample production
Bacterial over-expression of PDZ domains was performed using
BL21 DE3 Escherichia coli cells in 300 ml of M9 minimal medium
supplemented with 15NH4Cl at 37oC until an OD600 of 0.6 was
reached. Cultures were then adjusted to 0.5 mM isopropyl-D-thio-
galactopyranoside (IPTG) and transferred to 150C overnight.
Plasmid loss was suppressed by adding 15 mg/ml of kanamycin to
the expression media. Expression cultures were harvested by
centrifugation. The pellets were stored at 220oC.
MBP-PDZ domains purification
Bacterial expression of 15N-labeled 66His-MBP-PDZ constructs
were sonicated in buffer A (50 mM Tris-HCl at pH 6.8, 200 mM
NaCl, 1 mM DTT) supplemented with 1 mg/ml DNase I and RNase
A and EDTA-free anti-protease cocktail inhibitor (Roche), cleared by
ultracentrifugationat60000:gandfiltered(Millipore0.22 mm).MBP-
PDZ extracts were loaded on an amylose column (New England
Biolabs) pre-equilibrated with buffer A. Protein was eluted with buffer
A supplemented with 10 mM maltose. MBP-PDZ samples were then
subjected to a 15 hour ultracentrifugation at 130000:gp r i o rt o
loading on a Hiload 16/60 Superdex 75 gel-filtration column
(Amersham Biosciences) pre-equilibrated with buffer B (20 mM
sodium phosphate at pH 6.8, 200 mM NaCl) resulting in pure and
mono-disperse protein samples according to the column calibration.
The concentration of purified MBP-PDZ fusion samples was
evaluated from UV absorption measurements at 280 nm.A f t e r
SPR experiments MBP-PDZ fusions were cleaved by TEV and PDZ
domains were separated from MBP by gel size exclusion chroma-
tography. Subsequently, 1H-15N heteronuclear single quantum
coherence (HSQC) spectra were recorded on a 600 MHz Bruker
instrument in order to verify structural integrity of the domains.
Synthetic peptides
The synthetic peptide 16E6L/V (RSSRTRRETQV), corre-
sponding to the last 11 C-terminal residues of HPV16 E6 with the
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Peptide Synthesis Service, IGBMC, France. Lyophilised peptide
was re-suspended in water, passed on a NAP-5 desalting column
(GE Healthcare) in order to remove residual contaminants. The
desalted peptide was lyophilised prior to its dilution into buffer A.
The peptide was checked by homonuclear 2D NMR experiments
and its concentration estimated to be at 6 mM by measuring the
peptide bond absorption at 205 nm as described previously [40].
All other synthetic peptides with biotin at N-terminus that were
used as ligand in surface plasmon resonance experiments were
synthesised by JPT Peptide Technologies GmbH, Berlin, Ger-
many. Lyophilised peptides were re-suspended in water at a final
concentration at 10 mM. The pH of peptide solution was adjusted
to 6.8.
Surface plasmon resonance (SPR) measurements
Data were collected on a Biacore 2000 instrument (Biacore AB/
GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) at
25oC. SPR experiments (ligand immobilisation and binding
measurements) have been performed as described in Fournane
et al. [40]. Briefly, biotinylated peptides (instead of GST-fused
recombinant peptides) were immobilised on CM5 sensorchips on
which Neutravidin was previously attached. The MBP-PDZ
domain analyte was injected at 8 to 10 different concentrations
ranging from 0 up to 30 mM. Data were processed using the
BiaEvaluation 3.2 software (Biacore AB/GE Healthcare Bio-
Sciences Corp.) using ‘‘double referencing’’ [78] in which
sensorgrams were corrected for buffer effects and bulk refractive
index changes. Representative sensorgrams are shown in
Figure 5A.
The steady-state binding signal (Req) was derived by averaging
the signals in a five second window at equilibrium. Steady-state
analysis was performed by fitting the average signal Req as a
function of total MBP-PDZ concentrations, assuming a simple 1:1
interaction binding isotherm model. For many weak interactions
we observed calculated binding affinities (KD) with fits that
produced high x2 suggesting that the KD were likely to be
inaccurate (see Table S4). Reasons for this inaccuracy are likely to
be the following: 1. As previously described [40], several
repetitions of all the measurements are required to determine
accurate KD. In our case, such repetitions were not achievable in
reasonable time due to the large amount of interactions measured
in this study. 2. The highest injected analyte concentration restricts
the maximal KD (weakest interaction) that can be accurately
obtained. 3. A KD is estimated based on a mathematical
extrapolation of observed Req signals leading to additional
uncertainty. Based on these reasons, we considered the calculated
KD not as accurate enough to be used for absolute binding
strength comparison in this study. We rather performed a relative
analysis of binding strengths using directly Req signals which are
not biased by any mathematical assumption. We focussed on Req
signals obtained at 10 mM MBP-PDZ concentration, which have
been systematically measured in duplicate. The Req signal is
directly proportional to the molecular weight of the analyte and
the amount of immobilised ligand. Therefore, the Req signals were
normalised taking those into account before being used for binding
strength comparison. The large amount of raw experimental data,
which have been collected and the methodological approach that
we have developed for their exploitation will be presented and
discussed in detail in a separate, SPR-oriented paper.
Supporting Information
Dataset S1 PDZ interaction and non-interaction test
datasets. The archive contains three files, one for each test
dataset established: interactions, non-interactions with PDZ-
binding motif, and non-interactions without PDZ-binding motif.
First column: PDZ domain, second column: name of binder, third
column: C-terminus of binder.
(BZ2)
Dataset S2 Prediction results of proteome-wide screen
for MAGI1 and SCRIB PDZ-binding ligands using the
predictor of Chen et al. [27]. The prediction results were
performed in binary mode using a cutoff of 0.5 and are provided
without any additional filtering. No result file is provided for the
PDZ domain MAGI1-1/6 because the screen did not reveal any
peptides for this domain.
(BZ2)
Dataset S3 Alignment of human PDZ domains. The
archive contains an alignment in fasta format of 95 PDZ domains.
These include all PDZ domains that occur in the three test datasets
as well as all MAGI1 and SCRIB PDZ domains. Additionally, a
file is provided containing a translation between the PDZ domain
names used in the test datasets and the PDZ domain names used
in the alignment.
(BZ2)
Dataset S4 Implementation of the predictor of Chen
et al. [27]. The archive contains data files and python scripts
necessary to launch the predictor. The only prerequisite for
running the program is an installed python version. Check the
README.txt for more information.
(BZ2)
Table S1 Diversity of amino acids at last five positions
of PDZ-binding peptides in the training data of Chen
et al. [27].
(PDF)
Table S2 Filtered numbers of proteins predicted to
bind to 1, 2, 3, … or all PDZ domains of MAGI1 (6 PDZs)
or SCRIB (4 PDZs).
(PDF)
Table S3 Annotations for all proteins tested experimen-
tally in this work for interaction to MAGI1 and SCRIB.
The table contains UniProt IDs and information about biological
functions of the proteins with regard to PDZ domain binding as
well as published information on interactions with PDZ domain-
containing proteins.
(PDF)
Table S4 Experimental data for all interactions mea-
sured. The table contains ‘‘double referenced’’ and normalised
Req signals obtained for a 10 mM analyte concentration as well as
tentative calculated KD assuming a simple 1:1 interaction binding
isotherm model. These KD have to be considered with caution,
especially for interactions for which weak RU signals were
obtained.
(PDF)
Text S1 Recommendations for application of the pre-
dictor of Chen et al. [27].
(TXT)
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